Hepatitis C virus seroprevalence in the Netherlands

Eur J Public Health. 2012 Dec;22(6):819-21. doi: 10.1093/eurpub/cks013. Epub 2012 Mar 29.

Abstract

A population-based anti-hepatitis C virus (HCV) prevalence is important for surveillance purposes and it provides an insight into the burden of disease. In The Netherlands, a recent HCV seroprevalence estimate is not available. This national population-based cross-sectional serosurvey (PIENTER-2) resulted in a weighted national HCV seroprevalence of 0.30% (95% confidence interval 0.05-0.55%). About 70% of the HCV positive individuals found were born in an HCV-endemic country.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cross-Sectional Studies
  • Female
  • Genotype
  • Hepacivirus / genetics
  • Hepacivirus / immunology*
  • Hepatitis C / blood
  • Hepatitis C / diagnosis
  • Hepatitis C / epidemiology*
  • Hepatitis C Antibodies / blood
  • Humans
  • Immunoenzyme Techniques
  • Immunologic Factors
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • Population Surveillance
  • Prevalence
  • RNA, Viral / analysis
  • Risk Factors
  • Seroepidemiologic Studies
  • Socioeconomic Factors
  • Surveys and Questionnaires
  • Young Adult

Substances

  • Hepatitis C Antibodies
  • Immunologic Factors
  • RNA, Viral